047920 — HLB Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapNeutral

Annual balance sheet for HLB Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	R2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	14,043	79,253	25,545	24,624	25,874
Net Total Accounts Receivable
Net Total Receivables	8,070	8,483	13,373	16,808	18,351
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	29,018	94,977	51,468	59,946	71,575
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	15,315	8,904	53,954	51,612	48,358
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	45,846	111,420	127,632	142,177	141,352
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	23,092	61,981	45,507	52,857	48,896
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	27,943	66,798	49,248	56,249	53,198
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	17,903	44,622	78,385	85,929	88,153
Total Liabilities & Shareholders' Equity	45,846	111,420	127,632	142,177	141,352
Total Common Shares Outstanding